Schools gain federal funding to stock naloxone and train staff on overdose response
H.R. 2383 — Protecting Kids from Fentanyl Act of 2025 · Filed by Joe Neguse (D-CO) · 9 cosponsors · Introduced Mar 26, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill amends federal law to allow schools to use existing Preventive Health and Health Services Block Grants to buy naloxone (Narcan) and other opioid-reversal drugs, train staff to administer them, and teach students about fentanyl dangers. It expands the permitted uses of a funding stream already available to states and localities, adding three new eligible activities without requiring new appropriations.
Why we flagged it
The bill is a straightforward expansion of eligible uses for an existing federal public-health funding stream, aimed at equipping schools with overdose-reversal medication and training. It is a targeted response to fentanyl-related overdose deaths among youth.
What the text implies
- Naloxone access in schools may reduce barriers to emergency response for overdose events occurring on school grounds, potentially improving survival outcomes for students and staff.
- Fentanyl awareness education in schools may increase youth recognition of overdose risk and reduce stigma around opioid-use disorder, supporting broader public-health messaging.
The full analysis lists 3 implications of this text.
Who stands to gain
naloxone manufacturers (Emergent BioSolutions, Kaléo, others); schools and school districts (access to federal funding for equipment and training)